Home
/
Co-Diagnostics, Inc.
/
Financials
/
Quarterly
Co-Diagnostics, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Co-Diagnostics, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$9.7K
May 14, 2018
Q3
2017
Sep 30, 2017
$2.6K
Nov 14, 2017
Q2
2017
Jun 30, 2017
$2.5K
Aug 25, 2017
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$145.4K
Nov 13, 2025
Q2
2025
Jun 30, 2025
$162.9K
Aug 14, 2025
Q1
2025
Mar 31, 2025
$50.3K
May 8, 2025
Q3
2025
Sep 30, 2024
$641.1K
Nov 13, 2025
Q2
2025
Jun 30, 2024
$2.66M
Aug 14, 2025
Q1
2025
Mar 31, 2024
$467.9K
May 8, 2025
Q3
2024
Sep 30, 2023
$2.46M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$197.8K
Aug 8, 2024
Q1
2024
Mar 31, 2023
$602.0K
May 9, 2024
Q3
2023
Sep 30, 2022
$5.09M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$5.02M
Aug 10, 2023
Q1
2023
Mar 31, 2022
$22.70M
May 11, 2023
Q3
2022
Sep 30, 2021
$30.10M
Nov 10, 2022
Q2
2022
Jun 30, 2021
$27.36M
Aug 11, 2022
Q1
2022
Mar 31, 2021
$20.02M
May 12, 2022
Q3
2021
Sep 30, 2020
$21.82M
Nov 12, 2021
Q2
2021
Jun 30, 2020
$24.04M
Aug 12, 2021
Q1
2021
Mar 31, 2020
$1.55M
May 13, 2021
Q3
2020
Sep 30, 2019
$41.4K
Nov 16, 2020
Q2
2020
Jun 30, 2019
$61.6K
Nov 3, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($5.89M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($7.73M)
Aug 14, 2025
Q3
2025
Jun 30, 2025
($7.73M)
Nov 13, 2025
Q1
2025
Mar 31, 2025
($7.53M)
May 8, 2025
Q2
2025
Mar 31, 2025
($7.53M)
Aug 14, 2025
Q3
2025
Mar 31, 2025
($7.53M)
Nov 13, 2025
Q3
2025
Sep 30, 2024
($9.70M)
Nov 13, 2025
Q3
2025
Jun 30, 2024
($7.60M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($7.60M)
Aug 14, 2025
Q2
2025
Mar 31, 2024
($9.31M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($9.31M)
May 8, 2025
Q3
2025
Mar 31, 2024
($9.31M)
Nov 13, 2025
Q3
2024
Sep 30, 2023
($5.98M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($8.92M)
Aug 8, 2024
Q3
2024
Jun 30, 2023
($8.92M)
Nov 7, 2024
Q3
2024
Mar 31, 2023
($5.76M)
Nov 7, 2024
Q1
2024
Mar 31, 2023
($5.76M)
May 9, 2024
Q2
2024
Mar 31, 2023
($5.76M)
Aug 8, 2024
Q3
2023
Sep 30, 2022
($1.36M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($2.69M)
Aug 10, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($7.01M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($8.06M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($8.55M)
May 8, 2025
Q3
2025
Sep 30, 2024
($10.23M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($7.68M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($10.26M)
May 8, 2025
Q3
2024
Sep 30, 2023
($8.94M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($11.99M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($9.95M)
May 9, 2024
Q3
2023
Sep 30, 2022
($6.54M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($4.15M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
$9.82M
May 11, 2023
Q3
2022
Sep 30, 2021
$13.63M
Nov 10, 2022
Q2
2022
Jun 30, 2021
$11.79M
Aug 11, 2022
Q1
2022
Mar 31, 2021
$10.33M
May 12, 2022
Q3
2021
Sep 30, 2020
$12.04M
Nov 12, 2021
Q2
2021
Jun 30, 2020
$14.71M
Aug 12, 2021
Q1
2021
Mar 31, 2020
($1.08M)
May 13, 2021
Q3
2020
Sep 30, 2019
($1.65M)
Nov 16, 2020
Q2
2020
Jun 30, 2019
($1.37M)
Nov 3, 2020